Kestra Medical Technologies (KMTS) Revenue (2024 - 2026)

Kestra Medical Technologies (KMTS) has reported Revenue for 3 consecutive years, with $28.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Revenue rose 66.18% year-over-year to $28.6 million in Q2 2026; TTM through Apr 2026 was $95.1 million, a 59.03% increase from a year earlier, with the FY2026 full-year figure at $95.1 million, up 59.03% from the prior year.
• Revenue was $28.6 million for Q2 2026 at Kestra Medical Technologies, up from $24.6 million in the prior quarter.
• Over five years, Revenue peaked at $28.6 million in Q2 2026 and troughed at $8.3 million in Q1 2024.
• A 3-year average of $17.3 million and a median of $16.2 million in 2025 frame the typical range for Revenue.
• The widest YoY moves for Revenue: up 82.31% in 2025, down 51.55% in 2025.
• Over 3 years, Revenue stood at $14.7 million in 2024, then jumped by 53.4% to $22.6 million in 2025, then advanced by 26.91% to $28.6 million in 2026.
• The last three Revenue figures came in at $28.6 million (Q2 2026), $24.6 million (Q1 2026), and $22.6 million (Q4 2025), per Business Quant data.